Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$340K Buy
1,675
+23
+1% +$5.02K 0.11% 61
2019
Q4
$398K Sell
1,652
-19
-1% -$4.19K 0.09% 61
2019
Q3
$323K Sell
1,671
-206
-11% -$39.5K 0.07% 71
2019
Q2
$341K Buy
1,877
+216
+13% +$38.7K 0.08% 76
2019
Q1
$316K Sell
1,661
-325
-16% -$62.1K 0.07% 69
2018
Q4
$387K Buy
1,986
+1
+0.1% +$195 0.09% 61
2018
Q3
$412K Buy
1,985
+168
+9% +$33.1K 0.08% 68
2018
Q2
$335K Buy
1,817
+965
+113% +$171K 0.07% 80
2018
Q1
$145K Buy
+852
New +$156K 0.03% 161

Other funds holding AMGN

JOYN Advisors's AMGN Position: Q1 2020 in Review

JOYN Advisors increased its Amgen (AMGN) stake by 1.4% in Q1 2020, buying an estimated $5.02K and bringing the position to 1,675 shares worth $340K. The position accounts for 0.11% of the portfolio, ranked #61.

JOYN Advisors first reported a position in AMGN in Q1 2018 and has held it in 9 quarters since. The position peaked at $412K in Q3 2018. 2,029 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

  • JOYN Advisors held 1,675 shares of Amgen worth $340K as of Q1 2020.
  • JOYN Advisors bought 23 Amgen shares in Q1 2020, an estimated $5.02K.
  • Amgen made up 0.11% of JOYN Advisors's portfolio in Q1 2020, its #61 holding.
  • JOYN Advisors first reported a position in Amgen in Q1 2018 and has held it in 9 quarters since.
  • JOYN Advisors's Amgen position peaked at $412K in Q3 2018.
  • 2,029 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on JOYN Advisors's 13F filing for Q1 2020, filed 30 Apr 2020.